Kari C Nadeau
Primary Faculty

Kari C Nadeau

John Rock Professor of Climate and Population Studies

Environmental Health

Other Positions

Chair, Department of Environmental Health

Environmental Health

Harvard T.H. Chan School of Public Health

Lecturer on Committee on Degrees in Environmental Science and Public Policy

Environmental Science and Public Policy -Oth Acad

Harvard Faculty of Arts and Sciences


Overview

Dr. Kari Nadeau is the Chair of the Department of Environmental Health at Harvard School of Public Health and John Rock Professor of Climate and Population Studies. She practices Allergy, Asthma, Immunology in children and adults. She has published over 400+ papers, many in the field of climate change and health. Dr. Nadeau, with a team of individuals and patients and families, has been able to help major progress and impact in the clinical fields of immunology, infection, asthma and allergy. Dr. Nadeau is a member of the National Academy of Medicine and the U.S. EPA Children's Health Protection Committee.

For more than 30 years, she has devoted herself to understanding how environmental and genetic factors affect the risk of developing allergies and asthma, especially wildfire-induced air pollution. Her laboratory has been studying air pollution and wildfire effects on children and adults, including wildland firefighters. Many of the health issues involving individuals and the public are increasing because of global warming, sustainability practices, and extreme weather conditions. She oversees a team working on air pollution and wildfire research along with a multidisciplinary group of community leaders, firefighters, engineers, scientists, lawyers, and policy makers. Dr. Nadeau was appointed as a member of the U.S. Federal Wildfire Commission in 2022.

Dr. Nadeau works with other organizations and institutes across the world. She is working with the WHO on a scoping review and report for health ministers and policy makers on wildland fires: how to mitigate, adapt, and follow UN SDG's to create resiliency and co-benefits in communities, especially LMICs.

She also launched four biotech companies, and founded the Climate Change and Health Equity Task Force and started the Sustainability Health Seed Grant initiative and Climate Change and Health Fellowship program at Stanford. She also developed climate change and health courses at Stanford.
She also has served on the Scientific Advisory Board of the U.S. EPA.

Dr. Nadeau earned her MD/PhD from Harvard Medical School in 1995, completing her doctoral work in biochemistry and immunology, followed by a pediatric internship and residency at Boston Children's Hospital (1995-1997). She moved to California for a fellowship in the Stanford-UCSF Allergy, Asthma, and Immunology Program (2003-2006), joining the Stanford Medical School faculty as an instructor, followed by promotions to assistant professor (2008), associate professor (2011), and professor (2015).


Bibliography

Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.

Ozonoff A, Jayavelu ND, Liu S, Melamed E, Milliren CE, Qi J, Geng LN, McComsey GA, Cairns CB, Baden LR, Schaenman J, Shaw AC, Samaha H, Seyfert-Margolis V, Krammer F, Rosen LB, Steen H, Syphurs C, Dandekar R, Shannon CP, Sekaly RP, Ehrlich LIR, Corry DB, Kheradmand F, Atkinson MA, Brakenridge SC, Higuita NIA, Metcalf JP, Hough CL, Messer WB, Pulendran B, Nadeau KC, Davis MM, Sesma AF, Simon V, van Bakel H, Kim-Schulze S, Hafler DA, Levy O, Kraft M, Bime C, Haddad EK, Calfee CS, Erle DJ, Langelier CR, Eckalbar W, Bosinger SE, Peters B, Kleinstein SH, Reed EF, Augustine AD, Diray-Arce J, Maecker HT, Altman MC, Montgomery RR, Becker PM, Rouphael N.

Nat Commun. 2024 Jan 03. 15(1):216. PMID: 38172101

Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208].

Ozonoff A, Schaenman J, Jayavelu ND, Milliren CE, Calfee CS, Cairns CB, Kraft M, Baden LR, Shaw AC, Krammer F, van Bakel H, Esserman DA, Liu S, Sesma AF, Simon V, Hafler DA, Montgomery RR, Kleinstein SH, Levy O, Bime C, Haddad EK, Erle DJ, Pulendran B, Nadeau KC, Davis MM, Hough CL, Messer WB, Agudelo Higuita NI, Metcalf JP, Atkinson MA, Brakenridge SC, Corry D, Kheradmand F, Ehrlich LIR, Melamed E, McComsey GA, Sekaly R, Diray-Arce J, Peters B, Augustine AD, Reed EF, Altman MC, Becker PM, Rouphael N.

EBioMedicine. 2023 Dec. 98:104860. PMID: 37918220


News

Climate change contributing to rise in immune health problems

Diseases related to problems in immune health—from nasal allergies to food allergies to rheumatoid arthritis to colorectal cancer—have spiked in recent years, and climate change appears to be playing a role, according to Harvard Chan School’s Kari Nadeau.

Experts debrief on COP28 climate and health takeaways

Members of the Harvard community who attended COP28—the two-week international climate summit held in late 2023 in Dubai—gathered January 30 to discuss key takeaways, lessons learned, and next steps in the climate and health arena.

Investing in climate resilience benefits people, planet

Extreme weather events caused by climate change are costing trillions of dollars in damages, but making investments to boost climate resilience would both save money in the long run and protect people’s health, said Harvard Chan School’s Kari…